STOCK TITAN

Sentry-Q: Quantum-Powered Security Platform Leads the Way in Meeting New U.S. Healthcare Cybersecurity Proposed Standards

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Quantum eMotion (QNCCF) has launched Sentry-Q, a quantum-powered security platform designed to protect digital therapeutics against cyber threats. The platform's release aligns with new U.S. healthcare cybersecurity regulations proposed in response to recent major healthcare data breaches at organizations like Ascension and UnitedHealth.

Sentry-Q utilizes pure Entropy-as-a-Service (EaaS) generated by QRNG2 technology, integrated with classical and post-quantum cryptography. The platform meets the latest U.S. healthcare cybersecurity recommendations and has achieved ISO/IEC 27001:2022 certification. The company has also granted stock options to its CTO (600,000 shares) and CFO (350,000 shares).

Loading...
Loading translation...

Positive

  • Platform meets new U.S. healthcare cybersecurity regulations
  • Achieved ISO/IEC 27001:2022 certification for security management
  • Successfully commercialized Sentry-Q platform

Negative

  • Stock dilution through executive stock option grants of 950,000 shares

News Market Reaction

+30.13%
1 alert
+30.13% News Effect

On the day this news was published, QNCCF gained 30.13%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Montreal, Quebec--(Newsfile Corp. - December 30, 2024) - Quantum eMotion (TSXV: QNC) (OTCQB: QNCCF) (QeM) recently announced the commercialization of its quantum-powered security platform, Sentry-Q, designed to fortify digital therapeutics (DTx) against advanced cyber threats. This launch is timely, coinciding with newly proposed healthcare cybersecurity regulations aimed at addressing rising vulnerabilities and underscoring the urgency of safeguarding healthcare systems.

Last week, the U.S. government proposed new cybersecurity regulations to mitigate the impact of healthcare data breaches. This initiative responds to significant cyberattacks on healthcare organizations such as Ascension and UnitedHealth, which have compromised the sensitive information of millions of Americans. The proposals include measures such as enhanced data encryption to prevent unauthorized access even if data is leaked and implementing compliance checks to ensure that networks adhere to cybersecurity standards (https://www.hhs.gov/about/news/2024/12/27/hhs-office-civil-rights-proposes-measures-strengthen-cybersecurity-health-care-under-hipaa.html).

QeM's cutting-edge technology fully meets the latest U.S. healthcare cybersecurity recommendations. Its Sentry-Q platform harnesses the power of pure Entropy-as-a-Service (EaaS), generated by its advanced QRNG2 technology, seamlessly integrated with classical and post-quantum cryptography (PQC). This robust approach ensures the secure transmission of sensitive healthcare data, providing real-time protection and safeguarding confidentiality against both current and emerging quantum threats.

By meeting regulatory requirements, QeM's technology helps healthcare organizations proactively counter future threats while advancing secure digital transformation. QeM has achieved the prestigious ISO/IEC 27001:2022 certification. This certification encompasses Quantum eMotion's security management of applications and systems for its quantum-based cybersecurity software and hardware solutions, including cryptographic solutions.

On December 13, 2024 the Board of QeM granted Edward Lawrence Moore, CTO, 600,000 options to purchase common shares, and Marc Rousseau, CFO was granted 350,000 options to purchase common shares.

About QeM

The Company aims to address the growing demand for affordable hardware and software security for connected devices. QeM has become a pioneering force in classical and quantum cybersecurity solutions thanks to its patented Quantum Random Number Generator, a security solution that exploits the built-in unpredictability of quantum mechanics and promises to provide enhanced protection for high-value assets and critical systems.

The Company intends to target highly valued Financial Services, Healthcare, Blockchain Applications, Cloud-Based IT Security Infrastructure, Classified Government Networks and Communication Systems, Secure Device Keying (IOT, Automotive, Consumer Electronics) and Quantum Cryptography.

For further information, please visit our website at https://www.quantumemotion.com/ or contact:

Francis Bellido, Chief Executive Officer
Tel: 514.956.2525
Email: info@quantumemotion.com
Website: www.quantumemotion.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release may contain forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to vary materially from targeted results. Such risks and uncertainties include those described in the Corporation's periodic reports including the annual report or in the filings made by Quantum from time to time with securities regulatory authorities.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235477

FAQ

What is Quantum eMotion's (QNCCF) Sentry-Q platform?

Sentry-Q is a quantum-powered security platform that uses Entropy-as-a-Service (EaaS) and QRNG2 technology to protect digital therapeutics against cyber threats, meeting new U.S. healthcare cybersecurity standards.

How does QNCCF's Sentry-Q comply with new U.S. healthcare regulations?

Sentry-Q meets the latest U.S. healthcare cybersecurity recommendations through advanced data encryption and quantum-based security features, ensuring protection against both current and future quantum threats.

What certifications has QNCCF's Sentry-Q platform received?

Quantum eMotion has received the ISO/IEC 27001:2022 certification for its security management of quantum-based cybersecurity software and hardware solutions.

How many stock options did QNCCF grant to executives in December 2024?

On December 13, 2024, QNCCF granted 600,000 stock options to CTO Edward Lawrence Moore and 350,000 stock options to CFO Marc Rousseau, totaling 950,000 options.
Quantum Emotion Corp

OTC:QNCCF

QNCCF Rankings

QNCCF Latest News

QNCCF Stock Data

177.01M
210.79M
3.82%
0.02%
Semiconductors
Technology
Link
Canada
Montreal